Skip to main content

Comparison of MRI and Somatostatin Receptor Scintigraphy (SRS) in Postsurgical Follow-Up of Meningioma

  • Conference paper
Radioactive Isotopes in Clinical Medicine and Research XXIII

Abstract

In this study SRS and MRI were compared in postsurgical follow-up of meningioma. Prior to and 2–3 months after surgery 27 patients received standard MRI as well as SRS after i.v. injection of 200 MBq In-111-octreotide. Planar whole-body images were obtained at 10 min, 1, 4, and 24 hrs. p.i., and SPECT was performed at 4 and 24 hrs p.i. Final diagnosis was proven histologically in all patients. Prior to surgery MRI showed focal contrast enhancement in all patients, and SRS revealed focal accumulation of In-111-octreotide in 27 patients. Thus, preoperative MRI and SRS yielded comparable results. After surgery MRI showed diffuse contrast enhancement in all patients. Thus, MRI did not allow to differentiate between tumor tissue and unspecific hyperperfusion. In contrast, SRS revealed focal accumulation of In-111-octreotide in 16 out of 27 patients indicating tumor remnants or relapse of meningioma. This resulted either in an operative revision or in more frequent follow-up examinations. In 11 out of 27 patients SRS was negative confirming total resection of meningioma. SRS has a significant impact in postsurgical follow-up in patients with meningioma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gokalp HZ, Arasil E, Erdogan A, Egemen N, Deda H, Cerci A. Tentorial menigiomas. Neuro-surgery 1995; 36: 46–51.

    CAS  Google Scholar 

  2. Risi P, Uske A, de Tribolet N. Meningiomas involving the anterior clinoid process. Br J Neuro-surg 1994; 8: 295–305.

    CAS  Google Scholar 

  3. DeMonte F. Surgery of skull base tumors. Curr Opin Oncol 1995; 7: 201–206.

    Article  PubMed  CAS  Google Scholar 

  4. Reubi JC, Laissue J, Krenning EP, Lamberts SWJ. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochim Molec Biol 1992; 43: 27–35.

    Article  CAS  Google Scholar 

  5. Reubi JC, Kvols L, Krenning EP, Lamberts SWJ. In vitro and in vivo detection of somatostatin receptors in human malignant tissue. Acta Ocol 1991; 30: 463–468.

    CAS  Google Scholar 

  6. Luyken C, Hildebrandt G, Scheidhauer K, Krisch B. Diagnostic value of somatostatin-receptor-scintigraphy in patients with intracranial tumours. Nuklearmediziner 1993; 16: 317–324.

    Google Scholar 

  7. Scheidhauer K, Hildebrand G, Luyken C, Schomäcker K, Klug N, Schicha H. Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences. Horm Metab Res 1993; 27: 59–62.

    CAS  Google Scholar 

  8. Jochens R, Cordes M, Wolters A, Richter W, Amthauer H, Stoltenburg-Didinger G, Maier-Hauff K, Felix R. Untersuchungen von Hirntumoren und Hirnmetastasen mit [111In-DTPA-D-Phe1]-Octreotide-SPECT. Klin Neurorad 1995; 5: 1–13.

    Google Scholar 

  9. Hildebrandt G, Scheidhauer K, Luyken C, Schicha H, Klug N, Dahms P, Krisch B. High sensitivity of the in vivo detection of somatostatin receptors by l11Indium-[DTPA-octreotide]-scintigraphy in meningioma patients. Acta Neurochir Wien 1994; 126: 63–71.

    Article  PubMed  CAS  Google Scholar 

  10. Maini CL, Tofani A, Sciuto R, Carapella C, Cioffi R, Crecco M. Scintigraphy visualization of somatostatin receptors in human meningiomas using 111-indium-DTPA-D-Phe-l-octreotide. Nucl Med Commun 1993; 14: 505–508.

    Google Scholar 

  11. Reubi JC, Lang W, Maurer R, Koper JW, Lamberts SWJ. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987; 47: 5758–5764.

    PubMed  CAS  Google Scholar 

  12. Bohuslavizki KH, Brenner W, Braunsdorf WEK, Behnke A, Tinnemeyer S, Hugo HH, Jahn N, Wolf H, Sippel C, Clausen M, Mehdorn HM, Henze E. Somatostatin receptor scintigraphy in the differential diagnosis of meningioma. Nucl Med Commun 1996; 17: 302–310.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this paper

Cite this paper

Klutmann, S. et al. (1999). Comparison of MRI and Somatostatin Receptor Scintigraphy (SRS) in Postsurgical Follow-Up of Meningioma. In: Bergmann, H., Köhn, H., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research XXIII. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8782-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8782-3_23

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9772-3

  • Online ISBN: 978-3-0348-8782-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics